Augmenting chemotherapy response through EMAP II combination in experimental pancreatic cancer

被引:0
|
作者
Awasthi, N. [1 ]
Schwarz, M. A. [1 ]
Yen, P. L. [1 ]
Schwarz, R. [1 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
关键词
D O I
10.1200/jco.2011.29.4_suppl.294
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
294
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Enhancing cytotoxic agent activity in experimental pancreatic cancer through EMAP II combination therapy
    Awasthi, Niranjan
    Schwarz, Margaret A.
    Schwarz, Roderich E.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (03) : 571 - 582
  • [2] Enhancing cytotoxic agent activity in experimental pancreatic cancer through EMAP II combination therapy
    Niranjan Awasthi
    Margaret A. Schwarz
    Roderich E. Schwarz
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 571 - 582
  • [3] Combination effects of bortezomib with gemcitabine and EMAP II in experimental pancreatic cancer
    Awasthi, Niranjan
    Schwarz, Margaret A.
    Schwarz, Roderich E.
    CANCER BIOLOGY & THERAPY, 2010, 10 (01) : 99 - 107
  • [4] Enhancing sorafenib-mediated sensitization to gemcitabine in experimental pancreatic cancer through EMAP II
    Niranjan Awasthi
    Changhua Zhang
    Stefan Hinz
    Margaret A Schwarz
    Roderich E Schwarz
    Journal of Experimental & Clinical Cancer Research, 32
  • [5] Enhancing sorafenib-mediated sensitization to gemcitabine in experimental pancreatic cancer through EMAP II
    Awasthi, Niranjan
    Zhang, Changhua
    Hinz, Stefan
    Schwarz, Margaret A.
    Schwarz, Roderich E.
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2013, 32
  • [6] In vivo monotherapy and combination treatment of pancreatic cancer with the antiendothelial agent EMAP-II
    S. Konduri
    M. A. Schwarz
    R. E. Schwarz
    Annals of Surgical Oncology, 2004, 11 : S65 - S66
  • [7] In vivo monotherapy and combination treatment of pancreatic cancer with the antiendothelial agent EMAP-II
    Konduri, S
    Schwarz, MA
    Schwarz, RE
    ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (02) : S65 - S66
  • [8] EMAP II-Based Antiangiogenic-Antiendothelial In Vivo Combination Therapy of Pancreatic Cancer
    Schwarz, Roderich E.
    Awasthi, Niranjan
    Konduri, Srivani
    Cafasso, Danielle
    Schwarz, Margaret A.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (05) : 1442 - 1452
  • [9] EMAP II-Based Antiangiogenic-Antiendothelial In Vivo Combination Therapy of Pancreatic Cancer
    Roderich E. Schwarz
    Niranjan Awasthi
    Srivani Konduri
    Danielle Cafasso
    Margaret A. Schwarz
    Annals of Surgical Oncology, 2010, 17 : 1442 - 1452
  • [10] Antitumor effects of EMAP II against pancreatic cancer through inhibition of fibronectin-dependent proliferation
    Schwarz, Roderich E.
    Awasthi, Niranjan
    Konduri, Srivani
    Caldwell, Lauren
    Cafasso, Danielle
    Schwarz, Margaret A.
    CANCER BIOLOGY & THERAPY, 2010, 9 (08) : 632 - 639